4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-020104
CHIEF MEDICAL OFFICER sold 22,000 shares at an average $26.32 ($578,966)
- CHIEF MEDICAL OFFICER acquired 22,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Paolini John F. CHIEF MEDICAL OFFICER | 2024-07-23 | Option exercise 10b5-1 | +22,000 | $1.86 | $40,920 | 69,803 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2024-07-23 | Sale 10b5-1 | −5,530 | $25.03 | $138,416 | 64,273 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2024-07-23 | Sale 10b5-1 | −7,924 | $26.36 | $208,877 | 56,349 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2024-07-23 | Sale 10b5-1 | −8,446 | $27.10 | $228,887 | 47,903 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2024-07-23 | Sale 10b5-1 | −100 | $27.87 | $2,787 | 47,803 | D |
| Derivatives | |||||||
| Paolini John F. CHIEF MEDICAL OFFICER | 2024-07-23 | Option exercise · Share Option 10b5-1 | −22,000 | 60,217 | D | ||
| Open-market sales · 22,000 sh · avg $26.32 · $578,966 | |||||||
Loading xslF345X05/form4-07252024_080729.xml…